Zhangzhou Pientzehuang Ownership

600436 Stock   232.67  0.44  0.19%   
Zhangzhou Pientzehuang Pharmaceutical retains a total of 603.32 Million outstanding shares. Zhangzhou Pientzehuang maintains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 63.67 (%) of Zhangzhou Pientzehuang outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Zhangzhou Pientzehuang in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Zhangzhou Pientzehuang, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The current year's Dividends Paid is expected to grow to about 822.9 M. The current year's Net Income Applicable To Common Shares is expected to grow to about 3 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 482.7 M.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhangzhou Pientzehuang Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Zhangzhou Stock Ownership Analysis

About 64.0% of the company shares are owned by insiders or employees . The company recorded earning per share (EPS) of 5.1. Zhangzhou Pientzehuang last dividend was issued on the 22nd of October 2024. The entity had 15:10 split on the 24th of May 2016. For more info on Zhangzhou Pientzehuang Pharmaceutical please contact the company at 86 59 6230 1955 or go to https://www.zzpzh.com.cn.

Zhangzhou Pientzehuang Outstanding Bonds

Zhangzhou Pientzehuang issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zhangzhou Pientzehuang uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zhangzhou bonds can be classified according to their maturity, which is the date when Zhangzhou Pientzehuang Pharmaceutical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Zhangzhou Stock

Zhangzhou Pientzehuang financial ratios help investors to determine whether Zhangzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhangzhou with respect to the benefits of owning Zhangzhou Pientzehuang security.